STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZTS
  4. [Form 4] Zoetis Inc. Insider Trading Activity

Zoetis (ZTS) director Reed gains shares through RSU vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zoetis Inc. director Willie M. Reed acquired company stock through restricted stock unit (RSU) vesting. On February 19, 2026, 1,619.3325 RSUs were exercised at $0.0000 per share, resulting in 1,619 shares of Zoetis common stock being issued.

Following the transaction, Reed directly owned 12,864 Zoetis common shares and held 1,936 RSUs, each representing a right to receive one share. The remaining RSUs are scheduled to vest and be settled in Zoetis common stock on February 18, 2026, subject to continued service and certain earlier-vesting events.

Positive

  • None.

Negative

  • None.
Insider Reed Willie M
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Unit 1,619.333 $0.00 --
Exercise Common Stock 1,619 $0.00 --
holding Restricted Stock Unit -- -- --
Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct); Common Stock — 12,864 shares (Direct)
Footnotes (1)
  1. Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. Each RSU vests and is settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025. Not applicable. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reed Willie M
(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY
(Street)
PARSIPPANY NJ 07054
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/19/2026 M 1,619 A (1) 12,864 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(2) (3) 02/19/2026 M 1,619.3325 (4) (5) Common Stock 1,619.3325 (1) 0 D
Restricted Stock Unit(2) (3) (6) (5) Common Stock 1,936 1,936 D
Explanation of Responses:
1. Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.
2. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
3. Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.
4. Each RSU vests and is settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025.
5. Not applicable.
6. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 02/23/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Zoetis (ZTS) director Willie M. Reed report?

Zoetis director Willie M. Reed reported acquiring common stock through RSU vesting. On February 19, 2026, 1,619.3325 restricted stock units were exercised at zero cost, issuing 1,619 Zoetis common shares as part of his equity compensation.

How many Zoetis (ZTS) shares did Willie M. Reed acquire and at what price?

Willie M. Reed acquired 1,619 Zoetis common shares through the vesting of 1,619.3325 RSUs. The RSUs converted at a price of $0.0000 per share, reflecting a stock-settled equity award rather than an open-market stock purchase.

What are restricted stock units (RSUs) in the Zoetis (ZTS) filing for Willie M. Reed?

In this Zoetis filing, each restricted stock unit represents a contingent right to receive one share of Zoetis common stock. RSUs vest on specified anniversaries of the grant date and are settled in shares, sometimes including additional dividend equivalent units.

What is Willie M. Reed’s Zoetis (ZTS) share ownership after the reported Form 4 transactions?

After the reported transactions, Willie M. Reed directly owned 12,864 Zoetis common shares. He also held 1,936 RSUs, each corresponding to one future share of Zoetis common stock upon vesting and settlement under the company’s equity plan.

When do Willie M. Reed’s remaining Zoetis (ZTS) RSUs vest and settle into shares?

The remaining RSUs for Willie M. Reed are scheduled to vest and be settled in Zoetis common stock on February 18, 2026. This vesting is subject to his continued service and may accelerate upon certain specified events under the plan.

Under which equity plan were the Zoetis (ZTS) RSUs granted to Willie M. Reed?

The RSUs and related dividend equivalent units were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. Each unit represents a right to receive one Zoetis common share once the vesting conditions are satisfied.